These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 23331480)
21. Real-time cardiovascular magnetic resonance T1 and extracellular volume fraction mapping for tissue characterisation in aortic stenosis. Backhaus SJ; Lange T; Beuthner BE; Topci R; Wang X; Kowallick JT; Lotz J; Seidler T; Toischer K; Zeisberg EM; Puls M; Jacobshagen C; Uecker M; Hasenfuß G; Schuster A J Cardiovasc Magn Reson; 2020 Jun; 22(1):46. PubMed ID: 32564773 [TBL] [Abstract][Full Text] [Related]
22. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA J Cardiovasc Magn Reson; 2012 May; 14(1):27. PubMed ID: 22548832 [TBL] [Abstract][Full Text] [Related]
24. Normal myocardial native T Burkhardt BEU; Menghini C; Rücker B; Kellenberger CJ; Valsangiacomo Buechel ER J Magn Reson Imaging; 2020 Mar; 51(3):897-903. PubMed ID: 31507010 [TBL] [Abstract][Full Text] [Related]
25. Assessment of myocardial injury after reperfused infarction by T1ρ cardiovascular magnetic resonance. Stoffers RH; Madden M; Shahid M; Contijoch F; Solomon J; Pilla JJ; Gorman JH; Gorman RC; Witschey WRT J Cardiovasc Magn Reson; 2017 Feb; 19(1):17. PubMed ID: 28196494 [TBL] [Abstract][Full Text] [Related]
26. Superiority of the extracellular volume fraction over the myocardial T1 value for the assessment of myocardial fibrosis in patients with non-ischemic cardiomyopathy. Inui K; Tachi M; Saito T; Kubota Y; Murai K; Kato K; Takano H; Amano Y; Asai K; Shimizu W Magn Reson Imaging; 2016 Oct; 34(8):1141-5. PubMed ID: 27215951 [TBL] [Abstract][Full Text] [Related]
27. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. Schelbert EB; Testa SM; Meier CG; Ceyrolles WJ; Levenson JE; Blair AJ; Kellman P; Jones BL; Ludwig DR; Schwartzman D; Shroff SG; Wong TC J Cardiovasc Magn Reson; 2011 Mar; 13(1):16. PubMed ID: 21375743 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886 [TBL] [Abstract][Full Text] [Related]
30. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction. Matsumoto H; Matsuda T; Miyamoto K; Shimada T; Mikuri M; Hiraoka Y JACC Cardiovasc Imaging; 2011 Jun; 4(6):610-8. PubMed ID: 21679895 [TBL] [Abstract][Full Text] [Related]
31. Blood correction reduces variability and gender differences in native myocardial T1 values at 1.5 T cardiovascular magnetic resonance - a derivation/validation approach. Nickander J; Lundin M; Abdula G; Sörensson P; Rosmini S; Moon JC; Kellman P; Sigfridsson A; Ugander M J Cardiovasc Magn Reson; 2017 Apr; 19(1):41. PubMed ID: 28376820 [TBL] [Abstract][Full Text] [Related]
32. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar. Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374 [TBL] [Abstract][Full Text] [Related]
33. Myocardial Native T Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571 [TBL] [Abstract][Full Text] [Related]
34. T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients. Bulluck H; White SK; Rosmini S; Bhuva A; Treibel TA; Fontana M; Abdel-Gadir A; Herrey A; Manisty C; Wan SM; Groves A; Menezes L; Moon JC; Hausenloy DJ J Cardiovasc Magn Reson; 2015 Aug; 17(1):73. PubMed ID: 26264813 [TBL] [Abstract][Full Text] [Related]
35. Regional contrast agent quantification in a mouse model of myocardial infarction using 3D cardiac T1 mapping. Coolen BF; Geelen T; Paulis LE; Nicolay K; Strijkers GJ J Cardiovasc Magn Reson; 2011 Oct; 13(1):56. PubMed ID: 21974927 [TBL] [Abstract][Full Text] [Related]
36. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361 [TBL] [Abstract][Full Text] [Related]
37. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. Neilan TG; Coelho-Filho OR; Shah RV; Abbasi SA; Heydari B; Watanabe E; Chen Y; Mandry D; Pierre-Mongeon F; Blankstein R; Kwong RY; Jerosch-Herold M JACC Cardiovasc Imaging; 2013 Jun; 6(6):672-83. PubMed ID: 23643283 [TBL] [Abstract][Full Text] [Related]
38. Myocardial T1 values in healthy volunteers measured with saturation method using adaptive recovery times for T1 mapping (SMART1Map) at 1.5 T and 3 T. Matsumoto S; Okuda S; Yamada Y; Suzuki T; Tanimoto A; Nozaki A; Jinzaki M Heart Vessels; 2019 Nov; 34(11):1889-1894. PubMed ID: 30976924 [TBL] [Abstract][Full Text] [Related]